Nantahala Capital Management, LLC

Position in TNGX — Tango Therapeutics, Inc.

CIK 1472322 New Canaan, CT

Position in TNGX

as of Jun 30, 2026 · filed Aug 19, 2026 Compact

Position Value

$15,650,600

-$10,508,855 QoQ

Shares Held

500,659

-60.0% QoQ

Ownership

0.297%

of shares outstanding

% of Portfolio

0.95%

of 13F equity value

Holder Rank

#59

of 247 holders

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Nantahala Capital Management, LLC holds $620,287,047 across 52 Biotechnology names. TNGX ranks #16 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SVRA	Savara Inc	6,976,810	$42,977,149
2	AVTX	Avalo Therapeutics, Inc.	1,862,250	$34,414,380
3	LBRX	Lb Pharmaceuticals Inc	1,052,894	$34,171,674
4	ABEO	Abeona Therapeutics Inc.	5,136,490	$31,743,508
5	ZVRA	Zevra Therapeutics, Inc.	1,797,476	$25,775,805
6	MLYS	Mineralys Therapeutics, Inc.	820,481	$22,136,577
7	QURE	uniQure N.V.	455,660	$20,987,699
8	AURA	Aura Biosciences, Inc.	2,951,030	$20,952,313

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,650,600	500,659	-60.0%	Shares	Sole	2026-08-19
2026-03-31	$26,159,455	1,250,452	-65.0%	Shares	Sole	2026-05-15
2025-12-31	$31,653,528	3,572,633	+97.4%	Shares	Sole	2026-02-13
2025-09-30	$15,203,563	1,809,948	-47.4%	Shares	Sole	2025-11-14
2025-06-30	$17,610,721	3,439,594	+15.1%	Shares	Sole	2025-08-14
2025-03-31	$4,093,536	2,987,983	+6.5%	Shares	Sole	2025-05-15
2024-12-31	$8,665,626	2,804,410	+2738.6%	Shares	Sole	2025-02-14
2022-03-31	$748,858	98,794	-1.2%	Shares	Sole	2022-05-13
2021-12-31	$1,094,000	100,000	0.0%	Shares	Sole	2022-02-14
2021-09-30	$1,293,000	100,000	—	Shares	Sole	2021-11-15
2021-03-31 BCTG	—	175,915	-12.0%	Shares	Sole	2021-05-14
2020-12-31 BCTG	—	200,000	0.0%	Shares	Sole	2021-02-16
2020-09-30 BCTG	—	200,000	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.